Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03934177 · ClinicalTrials.gov registry record · NA
Impact of Blueberry Consumption on Gastrointestinal Health
A NA study, sponsored by University of Nebraska Lincoln.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT03934177 is a NA study that has completed, run by University of Nebraska Lincoln. The registered enrollment target is 28 participants.
The verdict
NCT03934177, a NA study, has completed, sponsored by University of Nebraska Lincoln.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
This study will evaluate the impact of blueberry consumption on markers of gastrointestinal health including gut microbiota, intestinal permeability, and gut-derived inflammation in those vulnerable to a unhealthy gut milieu. All participants will consume a blueberry powder and a placebo in this crossover study.
Interventions
- DIETARY_SUPPLEMENT Placebo powder
- DIETARY_SUPPLEMENT Blueberry powder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2019-03-26 |
| Est. Completion | 2023-03-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03934177
The ClinicalTrials.gov registry entry for NCT03934177 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska Lincoln, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo powder is the first listed.
NCT03934177 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03934177 about?
NCT03934177 is a clinical study titled "Impact of Blueberry Consumption on Gastrointestinal Health". This study will evaluate the impact of blueberry consumption on markers of gastrointestinal health including gut microbiota, intestinal permeability, and gut-derived inflammation in those vulnerable to a unhealthy gut milieu. All participants will consume a blueberry powder and a placebo in this cro...
What is the current status of trial NCT03934177?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2019-03-26. Estimated completion is 2023-03-02.
What interventions are being tested in trial NCT03934177?
The interventions under investigation include: Placebo powder (DIETARY_SUPPLEMENT), Blueberry powder (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03934177?
This trial is sponsored by University of Nebraska Lincoln, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.